Contact Congress about S. 3822: Break Up Big Medicine Act
Big health care companies could not keep owning both medical providers and key health care middlemen. Covered companies would have one year to sell one side of the business, or face penalties and lawsuits.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Break Up Big Medicine Act is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on the Judiciary.
Latest action on S. 3822: Read twice and referred to the Committee on the Judiciary.
Who this affects: This bill mainly affects large health care companies that own more than one part of the health system. Patients, doctors, pharmacies, and local health systems could feel the effects if companies must sell provider groups, insurance units, pharmacy benefit managers, or wholesale businesses.
Why this matters: The bill matters because some large health care companies own both the care side and the payment or supply side. That can create a conflict when the same parent company can steer patients, prescriptions, or business to itself. The bill tries to reduce that risk by forcing separate ownership. Its effects on prices, access, and quality are uncertain and would depend on how companies, regulators, and courts respond.
Key provisions in S. 3822
- A company could not own medical providers and also own both an insurer and a pharmacy benefit manager. Pharmacy benefit managers are companies that help run prescription drug benefits.
- A company could not own medical providers and also own a drug or medical device wholesaler. The same rule applies if the company controls a management services organization that runs provider practices.
- Covered companies would have one year to sell one side of the business. They could choose which side to sell.
- The Federal Trade Commission and the Department of Justice antitrust leaders would have 30 days to issue guidance. That guidance must include early deadlines for selling the required businesses.
- A company that misses an early deadline would have to put 10% of its monthly profits in escrow, which means a held account. The company gets the money back if it finishes on time, but loses it to a federal fund if it misses the final deadline.
How Modern Action helps you take action on S. 3822
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Questions people ask about S. 3822
- What is S. 3822?
- Big health care companies could not keep owning both medical providers and key health care middlemen. Covered companies would have one year to sell one side of the business, or face penalties and lawsuits.
- How do I support or oppose S. 3822?
- Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.
- Who should I contact about S. 3822?
- Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.
- Can Modern Action explain S. 3822 before I act?
- Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.
